Evidence map›Paper›PMID 33669016›Full record

ReviewMolecules (Basel, Switzerland)2021

Polyphosphorhydrazone-Based Radical Dendrimers.

Vega Lloveras, José Vidal-Gancedo

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Emerging dendrimer-based RNA delivery strategies.Nanomedicine (London, England) · 2025
    Review
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Vega LloverasInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) and CIBER-BBN, Campus UAB, 08193 Bellaterra, Spain.ORCID 0000-0002-9653-3340
José Vidal-GancedoInstitut de Ciència de Materials de Barcelona (ICMAB-CSIC) and CIBER-BBN, Campus UAB, 08193 Bellaterra, Spain.
Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The search for new biomedical applications of dendrimers has promoted the synthesis of new radical-based molecules. Specifically, obtaining radical dendrimers has opened the door to their use in various fields such as magnetic resonance imaging, as anti-tumor or antioxidant agents, or the possibility of developing new types of devices based on the paramagnetic properties of organic radicals. Herein, we present a mini review of radical dendrimers based on polyphosphorhydrazone, a new type of macromolecule with which, thanks to their versatility, new metal-free contrast agents are being obtained, among other possible applications.

Indexed as

DendrimersFree RadicalsHumansHydrazonesMolecular StructureOrganophosphonatesPolymersDendrimersFree RadicalsHydrazonesOrganophosphonatesPolymerscontrast agentsmagnetic resonance imagingorganic radicalsPPH dendrimersradical dendrimers

Identifiers

PMID33669016
PMCPMC7956296
OpenAlexW3130258884

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.